{"id":716,"date":"2021-05-18T14:35:17","date_gmt":"2021-05-18T14:35:17","guid":{"rendered":"https:\/\/avadawebsites.wpengine.com\/science\/?page_id=716"},"modified":"2025-06-13T09:26:47","modified_gmt":"2025-06-13T07:26:47","slug":"neocor-home","status":"publish","type":"page","link":"https:\/\/neocor.fr\/","title":{"rendered":"Neocor Therapeutics – homepage"},"content":{"rendered":"

Pioneering the Future of Cardiac Health<\/p><\/h1><\/div><\/div><\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>

Our mission<\/p><\/h2><\/div>

<\/div><\/div>

Neocor\u2019s mission is to uncover novel innovative therapeutic approaches for heart regeneration and repair.<\/b><\/h4>\n<\/div>
<\/div>

Neocor is dedicated to pioneering transformative therapies in cardiac care.<\/p>\n

Our mission is to address the critical challenges in treating cardiac diseases, focusing on preventing cardiomyocyte death, promoting cellular regeneration, and halting fibrosis to preserve heart function.<\/span><\/p>\n

By innovatively targeting the root causes of heart disease, Neocor aims to revolutionize cardiac treatment, prevent the progression toward heart failure, and significantly improve both the lifespan and quality of life for those suffering from cardiac conditions.<\/span><\/p>\n

We are committed to advancing heart health through groundbreaking research, therapeutic innovation, and a relentless pursuit of solutions that regenerate, repair, and renew.<\/span><\/p>\n<\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/div>
<\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>

Our approach<\/h2><\/div>
<\/div><\/div>

Our technology combines two distinct and complementary approaches to treat ischemic and rare genetic cardiac diseases.
<\/h4>\n<\/div><\/div><\/div>
<\/i><\/div>

Promoting cardiomyocyte renewal<\/h2><\/div>
<\/div>
\n

By promoting cardiomyocyte regeneration, new integrated and functional cardiomyocytes will preserve cardiac performance.<\/p>\n<\/div><\/div><\/div>

<\/i><\/div>

Preventing cardiac fibrosis<\/h2><\/div>
<\/div>
\n

By preventing non contractile cardiac fibrosis deposition, cardiac contractility properties will be preserved.<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div><\/div>
<\/div>
<\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div><\/div>

Our Founding Team<\/h2><\/div>
<\/div><\/div>

We form a highly complementary and seasoned team mixing entrepreneurial spirit and scientific expertise in the field of cardiovascular research.<\/p>\n<\/div>

<\/div><\/div><\/div>
<\/div><\/div>
<\/div><\/div>
\"Matthieu<\/div><\/div>
Matthieu Metz<\/span>CEO - Founder<\/span><\/div><\/div>
Ecole Centrale Paris.
\nMaster of Science, UC Berkeley.<\/b>
\nMatthieu has various experiences in innovative fields. Prior to founding Neocor, he cofounded and led Innixim, a dental imaging tech firm, from 2014 to 2021, from R&D to an exit to a market leader.<\/div>
<\/a><\/div><\/div><\/div><\/div><\/div><\/div>
\"Francesca<\/div><\/div>
Francesca Rochais <\/span>CSO - Founder<\/span><\/div><\/div>
PhD - Research Supervisor<\/b>\n<\/p>\n

Francesca is the head of the \u201cHeart Development and Cardiac Regeneration\u201d team within Marseille Medical Genetics, with a focus on cardiac physiopathology and regeneration.<\/p>\n<\/div>

<\/a><\/div><\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div>
<\/div><\/div>

Our Scientific Advisory Board<\/h2><\/div>
<\/div><\/div>

Meet our Scientific Advisory Board, a diverse group of distinguished global experts from academia and industry who will help us guide our cutting-edge research. <\/p>\n<\/div>

<\/div><\/div><\/div>
<\/div><\/div>
\"Dr<\/div><\/div>
Dr Rodolphe Fischmeister<\/span><\/span><\/div><\/div>
INSERM Research Director<\/b><\/p>\n

Rodolphe has a deep expertise in heart failure and therapeutic innovation.<\/div>

<\/a><\/div><\/div><\/div><\/div><\/div><\/div>
\"Dr<\/div><\/div>
Dr Thierry Bordet<\/span><\/span><\/div><\/div>
CSO of Eyevensis.<\/b>
\nThierry's expertise includes rare diseases, gene therapy and clinical trials.<\/div>
<\/a><\/div><\/div><\/div><\/div><\/div><\/div>
\"Dr<\/div><\/div>
Dr Sanda Robelet<\/span><\/span><\/div><\/div>
CSO of Syncrosome<\/b>
\nSandra is an expert in preclinical studies for cardiovascular pathologies<\/div>
<\/a><\/div><\/div><\/div><\/div><\/div><\/div>
\"Pr<\/div><\/div>
Pr Jean-Sebastien Hulot<\/span><\/span><\/div><\/div>
Pr of Medicine, Cardiology, Pharmacology at HEGP Paris<\/b>
\nJean-S\u00e9bastien has a deep knowledge of cardiac diseases, gene therapy and clinical trials.<\/div>
<\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>
<\/div>
<\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div><\/div>

Our Partners<\/h2><\/div>
<\/div><\/div>

Their support fuels our collective ambition.<\/p>\n<\/div><\/div><\/div>

<\/div><\/div>
<\/span><\/div><\/div><\/div>
<\/span><\/div><\/div><\/div>
<\/span><\/div><\/div><\/div>
<\/span><\/div><\/div><\/div>
<\/span><\/div><\/div><\/div>
<\/span><\/div><\/div><\/div><\/div><\/div>
<\/div><\/div>
<\/div>
<\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>

Want to find out more ?<\/h2><\/div>
<\/div><\/div>

Curious to know more about us ?
Please reach out and send us a mail at : info@neocor.fr<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"class_list":["post-716","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/neocor.fr\/index.php\/wp-json\/wp\/v2\/pages\/716","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neocor.fr\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/neocor.fr\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/neocor.fr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/neocor.fr\/index.php\/wp-json\/wp\/v2\/comments?post=716"}],"version-history":[{"count":54,"href":"https:\/\/neocor.fr\/index.php\/wp-json\/wp\/v2\/pages\/716\/revisions"}],"predecessor-version":[{"id":976,"href":"https:\/\/neocor.fr\/index.php\/wp-json\/wp\/v2\/pages\/716\/revisions\/976"}],"wp:attachment":[{"href":"https:\/\/neocor.fr\/index.php\/wp-json\/wp\/v2\/media?parent=716"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}